0001144204-17-047782.txt : 20170913 0001144204-17-047782.hdr.sgml : 20170913 20170913082057 ACCESSION NUMBER: 0001144204-17-047782 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170913 DATE AS OF CHANGE: 20170913 EFFECTIVENESS DATE: 20170913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-294572 FILM NUMBER: 171082251 BUSINESS ADDRESS: STREET 1: 617 DETROIT STREET, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE STREET 2: SUITE 270 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 D 1 primary_doc.xml X0708 D LIVE 0000894158 Synthetic Biologics, Inc. 9605 MEDICAL CENTER DRIVE, SUITE 270 ROCKVILLE MD MARYLAND 20850 (301) 417-4364 NEVADA None ADEONA PHARMACEUTICALS, INC. PIPEX PHARMACEUTICALS, INC. SHEFFIELD PHARMACEUTICALS INC Corporation true Jeffrey Riley 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Executive Officer Director Steven Shallcross 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Executive Officer Jeffrey Kraws 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Director Scott Tarriff 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Director Jeffrey Wolf 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Director Joseph Sliman 9605 Medical Center Drive, Suite 270 Rockville MD MARYLAND 20850 Executive Officer Biotechnology Decline to Disclose 06b false 2017-09-11 false true false 12000000 12000000 12000000 0 false 1 0 0 0 Proceeds may be used to pay overhead and other corporate expenses which could include salaries false Synthetic Biologics, Inc. /s/ Steven Shallcross Steven Shallcross Chief Executive Officer 2017-09-13